Randomized contorol trial of transarterial chemoinfusion with cisplatin-lipiodol susupension or miriplatin-lipiodol suspension for advanced HCC - Randomized contorol trial of transarterial chemoinfusion for advanced HCC

First Department of Internal Medicine,Gifu University Hospital0 个研究点目标入组 98 人开始时间: 2010年5月1日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 98

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The 1-year survival rates in the cisplatin and miriplatin groups were 84.0% and 77.7%, and the 2-year survival rates were 60.0% and 51.8% respectively. (P = 0.905).The 1-year survival rates in the cisplatin and miriplatin groups with TAI alone were 71.4% and 71.4%, and the 2-year survival rates cannot be calculated yet. (P = 0.695).TE evaluation, the 1-year survival rates in TE3+4 and TE1+2 groups were 100% and 62.1%, and the 2-year survival rates were 66.7% and 33.1% respectively. (P = 0.0263).

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 80years-old（—）
性别: All

入选标准

未提供

排除标准

•1)Patienta with sever co-morbidity such as cardiac failure or renal failure 2)Patienta with a medical history of severe hypersensitivity 3)Patients who are pregnant,lactating or are suspected to be a pregnant 4)Patients who are concluded to be inappropriate to participate in this study by their physitians

研究者

发起方

First Department of Internal Medicine,Gifu University Hospital

相似试验

已完成

2 期

Clinical trial of postoperative adjuvant chemotherapy with carboplatin/paclitaxel according to the results of collagen gel droplet embedded culture drug sensitivity test (CD-DST) in completely resected non-small-cell lung cancerCompletely resected p-IB-IIIA non-small cell lung cancer

JPRN-C000000210Department of General Thoracic Surgery, Osaka University Graduate School of Medicine92

Unknown

不适用

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma

NCT04523467Eastern Hepatobiliary Surgery Hospital320

Unknown

2 期

Trial of Transcatheter Arterial Chemoembolization for Hepatocellular CarcinomaCarcinoma, Hepatocellular

NCT00843934Nihon University450

Unknown

不适用

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma

NCT02150317Eastern Hepatobiliary Surgery Hospital180

已完成

不适用

Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Multicentric Phase II StudyHead and neck squamous cell carcinoma at stage III and IV

JPRN-C000000306Department of Otorhinolaryngology and Head and Neck Surgery, Osaka University School of Medicine150